Cardiology 2025, the 28th Annual Update on Pediatric and Congenital Cardiovascular Disease, took place from February 19 to 23 in Lake Buena Vista, Florida. The conference, hosted by the Children’s Hospital of Philadelphia, brought together a diverse community of pediatric and congenital cardiovascular professionals and advocates, all united by this year’s theme: Hope, Heal, and … Read more
Please note that the text below is not a full transcript and has not been copyedited. For more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast, download the Medscape app or subscribe on Apple Podcasts, Spotify, or your preferred podcast provider. This podcast is intended for healthcare professionals only. … Read more
In women with signs of ischemia but no obstructive coronary artery disease (OCAD), intensive medical therapy did not reduce the first occurrence of a major cardiovascular event in the WARRIOR trial, but the trial was underpowered to show a definitive result. “This is a neutral trial and should not be considered a negative trial,” said … Read more
TOPLINE: Early introduction of atorvastatin vs placebo in patients with hypertension demonstrated significant benefits in reducing cardiovascular disease events, such as non-fatal myocardial infarction (MI) and coronary heart disease (CHD) events, over a 20-year follow-up period. METHODOLOGY: Researchers analysed data from the ASCOT lipid-lowering arm study and included 4605 UK participants with hypertension, at least … Read more
Wearable technologies such as smartwatches are providing physicians with new ways to monitor their patients’ health and detect cardiovascular risk factors. Metrics like daily step totals and average resting heart rate are already being used to predict cardiovascular health. Zhanlin Chen, a medical student at Northwestern University in Chicago, Illinois, however, has developed a new … Read more
Please note that the text below is not a full transcript and has not been copyedited. For more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast, download the Medscape app or subscribe on Apple Podcasts, Spotify, or your preferred podcast provider. This podcast is intended for healthcare professionals only. … Read more
Individuals testing positive for human papillomavirus (HPV) had a 40% greater risk for overall cardiovascular disease (CVD) than HPV-negative individuals, based on the data from nearly 250,000 patients. The findings were presented at the American College of Cardiology Annual Scientific Session and Expo. “Although high-risk HPV is known to play a role in anogenital cancers, … Read more
TOPLINE: Among adults aged 80 years or older on antihypertensive medications, intensive systolic blood pressure (SBP) control (below 130 mm Hg) was associated with a significantly lower risk for cardiovascular mortality than SBP of 130-160 mm Hg. METHODOLOGY: Current guidelines advocate for more intensive BP control but remain inconsistent and lack strong evidence for adults … Read more
Point-of-care (POC) testing can significantly increase routine lipid screening of preteen patients, according to findings from a study published in Pediatrics. At the beginning of the study, testing rates at three pediatric primary care sites in Pennsylvania were between 1% and 10% among preteens aged between 9 and 11 years, despite recommendations from the American … Read more
TOPLINE: Aggressive ablation provided more favorable outcomes at 12 months than regular ablation in patients with persistent atrial fibrillation (AF). Patients undergoing aggressive ablation also had enhanced AF and atrial tachycardia (AT)–free survival. METHODOLOGY: Previous studies suggest using aggressive ablation for persistent AF, but real-world evidence with the approach is lacking. Researchers conducted a retrospective … Read more